{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:45:15Z","timestamp":1783691115968,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U2004119"],"award-info":[{"award-number":["U2004119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["202300410361"],"award-info":[{"award-number":["202300410361"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Medical Award Foundation","award":["YXJL-2021-0072-0349"],"award-info":[{"award-number":["YXJL-2021-0072-0349"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10097-1","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T04:01:31Z","timestamp":1692072091000},"page":"1258-1267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transcatheter arterial chemoembolization using CalliSpheres beads loaded with arsenic trioxide for unresectable large or huge hepatocellular carcinoma: a prospective study"],"prefix":"10.1007","volume":"34","author":[{"given":"Xuhua","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangjian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-3717","authenticated-orcid":false,"given":"Xinwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"issue":"15","key":"10097_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380(15):1450\u20131462","journal-title":"N Engl J Med"},{"issue":"6","key":"10097_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00432-014-1866-1","volume":"141","author":"B Liu","year":"2015","unstructured":"Liu B, Huang JW, Li Y et al (2015) Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial. J Cancer Res Clin Oncol 141(6):1103\u20131108","journal-title":"J Cancer Res Clin Oncol"},{"key":"10097_CR3","doi-asserted-by":"publisher","first-page":"5565793","DOI":"10.1155\/2021\/5565793","volume":"2021","author":"Z Li","year":"2021","unstructured":"Li Z, Chen Q, Zhang W, Si G, Li J (2021) Jiao D et al Efficacy and safety of the arsenic trioxide\/lipiodol emulsion in the transcatheter arterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma. Can J Gastroenterol Hepatol 2021:5565793","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"10097_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.28453","volume":"64","author":"R Lencioni","year":"2016","unstructured":"Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF (2016) Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data. Hepatology 64(1):106\u2013116","journal-title":"Hepatology"},{"issue":"6","key":"10097_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12072-019-09981-0","volume":"13","author":"C Li","year":"2019","unstructured":"Li C, Wang MD, Lu L et al (2019) Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (>\/= 10 cm): a multicenter propensity matching analysis. Hepatol Int 13(6):736\u2013747","journal-title":"Hepatol Int"},{"issue":"3","key":"10097_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/jso.24501","volume":"115","author":"K Wakayama","year":"2017","unstructured":"Wakayama K, Kamiyama T, Yokoo H et al (2017) Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection. J Surg Oncol 115(3):324\u2013329","journal-title":"J Surg Oncol"},{"issue":"9","key":"10097_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/lt.20472","volume":"11","author":"TM Pawlik","year":"2005","unstructured":"Pawlik TM, Delman KA, Vauthey JN et al (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11(9):1086\u20131092","journal-title":"Liver Transpl"},{"issue":"7","key":"10097_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/hepr.13335","volume":"49","author":"S Miyayama","year":"2019","unstructured":"Miyayama S, Kikuchi Y, Yoshida M et al (2019) Outcomes of conventional transarterial chemoembolization for hepatocellular carcinoma >\/=10 cm. Hepatol Res 49(7):787\u2013798","journal-title":"Hepatol Res"},{"issue":"15","key":"10097_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS et al (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133(15):1630\u20131643","journal-title":"Blood"},{"issue":"1","key":"10097_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","volume":"8","author":"MA Kutny","year":"2022","unstructured":"Kutny MA, Alonzo TA, Abla O et al (2022) Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children\u2019s Oncology Group AAML1331 Trial. JAMA Oncol 8(1):79\u201387","journal-title":"JAMA Oncol"},{"key":"10097_CR11","doi-asserted-by":"publisher","first-page":"5773802","DOI":"10.1155\/2021\/5773802","volume":"2021","author":"X Wang","year":"2021","unstructured":"Wang X, Cao L, Wu J et al (2021) Exploring the mechanisms of arsenic trioxide (Pishuang) in hepatocellular carcinoma based on network pharmacology. Evid Based Complement Alternat Med. 2021:5773802","journal-title":"Evid Based Complement Alternat Med."},{"issue":"1","key":"10097_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2010.10.022","volume":"301","author":"Y Ma","year":"2011","unstructured":"Ma Y, Wang J, Liu L et al (2011) Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor- kappaB. Cancer Lett 301(1):75\u201384","journal-title":"Cancer Lett"},{"key":"10097_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2018.05.006","volume":"205","author":"N Sadaf","year":"2018","unstructured":"Sadaf N, Kumar N, Ali M, Ali V, Bimal S, Haque R (2018) Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells. Life Sci 205:9\u201317","journal-title":"Life Sci"},{"issue":"1","key":"10097_CR14","first-page":"1573","volume":"17","author":"F Zhang","year":"2018","unstructured":"Zhang F, Zhang CM, Li S et al (2018) Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis. Mol Med Rep 17(1):1573\u20132158","journal-title":"Mol Med Rep"},{"issue":"1","key":"10097_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10637-006-9004-9","volume":"25","author":"CC Lin","year":"2007","unstructured":"Lin CC, Hsu C, Hsu CH, Hsu WL, Cheng AL, Yang CH (2007) Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial. Invest New Drugs 25(1):77\u201384","journal-title":"Invest New Drugs"},{"issue":"6","key":"10097_CR16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","volume":"26","author":"G Vesselle","year":"2016","unstructured":"Vesselle G, Quirier-Leleu C, Velasco S et al (2016) Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma. Eur Radiol 26(6):1640\u20131648","journal-title":"Eur Radiol"},{"issue":"6","key":"10097_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","volume":"57","author":"MJ Song","year":"2012","unstructured":"Song MJ, Chun HJ, Song DS et al (2012) Comparative study between doxorubicin- eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 57(6):1244\u20131250","journal-title":"J Hepatol"},{"issue":"3","key":"10097_CR18","first-page":"1468","volume":"24","author":"XH Duan","year":"2020","unstructured":"Duan XH, Ju SG, Han XW et al (2020) Arsenic trioxide-eluting CalliSpheres beads is more effective and equally tolerant compared with arsenic trioxide\/lipiodol emulsion in the transcatheter arterial chemoembolization treatment for unresectable hepatocellular carcinoma patients. Eur Rev Med Pharmacol Sci 24(3):1468\u20131480","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"10097_CR19","first-page":"5511","volume":"12","author":"X Duan","year":"2020","unstructured":"Duan X, Li H, Han X et al (2020) Antitumor properties of arsenic trioxide-loaded CalliSpheres\u00ae microspheres by transarterial chemoembolization in VX2 liver tumor rabbits: suppression of tumor growth, angiogenesis, and metastasis and elongation of survival. Am J Transl Res 12(9):5511\u20135524","journal-title":"Am J Transl Res"},{"key":"10097_CR20","unstructured":"Health and Family Planning Commission of the People\u2019s Republic of China, Medical Affairs and Medical Administration Bureau (2017) Diagnosis and treatment specifications for primary liver cancer (2017 version) [J]. Chin J Gastroenterol 16 (7):13"},{"issue":"1","key":"10097_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52\u201360","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10097_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1634\/theoncologist.2018-0305","volume":"24","author":"S Liu","year":"2019","unstructured":"Liu S, Li H, Guo L et al (2019) Tumor size affects efficacy of adjuvant transarterial chemoembolization in patients with hepatocellular carcinoma and microvascular invasion. Oncologist 24(4):513\u2013520","journal-title":"Oncologist"},{"issue":"7\u20138","key":"10097_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1445-2197.2012.06079.x","volume":"82","author":"G Tsoulfas","year":"2012","unstructured":"Tsoulfas G, Mekras A, Agorastou P, Kiskinis D (2012) Surgical treatment for large hepatocellular carcinoma: does size matter? ANZ J Surg 82(7\u20138):510\u2013517","journal-title":"ANZ J Surg"},{"issue":"3","key":"10097_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000396","volume":"94","author":"JH Zhong","year":"2015","unstructured":"Zhong JH, Rodriguez AC, Ke Y, Wang YY, Wang L, Li LQ (2015) Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion. Medicine (Baltimore) 94(3):e396","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10097_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/bjs.10196","volume":"103","author":"YJ Chang","year":"2016","unstructured":"Chang YJ, Chung KP, Chang YJ, Chen LJ (2016) Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas. Br J Surg 103(11):1513\u20131520","journal-title":"Br J Surg"},{"issue":"1","key":"10097_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2036.2006.02704.x","volume":"23","author":"YH Huang","year":"2006","unstructured":"Huang YH, Wu JC, Chen SC et al (2006) Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment Pharmacol Ther 23(1):129\u2013135","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10097_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3727\/096504019X15662966719585","volume":"28","author":"J Sun","year":"2020","unstructured":"Sun J, Zhou G, Xie X et al (2020) Efficacy and safety of drug-eluting beads transarterial chemoembolization by CalliSpheres((R)) in 275 hepatocellular carcinoma patients: results from the Chinese CalliSpheres((R)) Transarterial Chemoembolization in Liver Cancer (CTILC) study. Oncol Res 28(1):75\u201394","journal-title":"Oncol Res"},{"issue":"5","key":"10097_CR28","first-page":"1956","volume":"24","author":"X Du","year":"2019","unstructured":"Du X, Chen D, Lin Z et al (2019) Efficacy of apatinib in advanced hepatocellular carcinoma with lung metastasis: a retrospective, multicenter study. J Buon 24(5):1956\u20131963","journal-title":"J BUON"},{"issue":"2","key":"10097_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jgh.13529","volume":"32","author":"HT Hu","year":"2017","unstructured":"Hu HT, Yao QJ, Meng YL et al (2017) Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: long-term outcome analysis. J Gastroenterol Hepatol 32(2):295\u2013300","journal-title":"J Gastroenterol Hepatol"},{"issue":"17","key":"10097_CR30","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/cncr.29456","volume":"121","author":"H Wang","year":"2015","unstructured":"Wang H, Liu Y, Wang X et al (2015) Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma. Cancer 121(17):2917\u20132925","journal-title":"Cancer"},{"key":"10097_CR31","doi-asserted-by":"publisher","first-page":"9979","DOI":"10.2147\/CMAR.S199188","volume":"11","author":"XH Duan","year":"2019","unstructured":"Duan XH, Li H, Ren JZ et al (2019) Hepatic arterial chemoembolization with arsenic trioxide eluting CalliSpheres microspheres versus lipiodol emulsion: pharmacokinetics and intratumoral concentration in a rabbit liver tumor model. Cancer Manag Res 11:9979\u20139988","journal-title":"Cancer Manag Res"},{"issue":"9","key":"10097_CR32","first-page":"5511","volume":"12","author":"X Duan","year":"2020","unstructured":"Duan X, Li H, Han X et al (2020) Antitumor properties of arsenic trioxide-loaded CalliSpheres((R)) microspheres by transarterial chemoembolization in VX2 liver tumor rabbits: suppression of tumor growth, angiogenesis, and metastasis and elongation of survival. Am J Transl Res 12(9):5511\u20135524","journal-title":"Am J Transl Res"},{"issue":"3","key":"10097_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020\u20131022","journal-title":"Hepatology"},{"issue":"3","key":"10097_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1148\/rg.2017160122","volume":"37","author":"AS Moustafa","year":"2017","unstructured":"Moustafa AS, Abdel Aal AK, Ertel N, Saad N, DuBay D, Saddekni S (2017) Chemoembolization of hepatocellular carcinoma with extrahepatic collateral blood supply: anatomic and technical considerations. Radiographics 37(3):963\u2013977","journal-title":"Radiographics"},{"issue":"11","key":"10097_CR35","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jvir.2016.04.034","volume":"27","author":"RP Lokken","year":"2016","unstructured":"Lokken RP, Fidelman N, Kolli KP, Kerlan RK Jr (2016) Safety and efficacy of doxorubicin drug-eluting embolic chemoembolization of hepatocellular carcinoma supplied by extrahepatic collateral arteries. J Vasc Interv Radiol 27(11):1698\u20131704","journal-title":"J Vasc Interv Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10097-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10097-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10097-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T11:03:54Z","timestamp":1707390234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10097-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["10097"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10097-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Xinwei Han.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University and registered in the Chinese Clinical Trial Registry (Registration Number: ChiCTR1800018418).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Prospective\u2022 Randomized controlled trial\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}